data review cycles

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Medidata Earns Top 'Luminary' AI Rating as Solutions Back 80% of FDA Drug Approvals

Medidata secures top 'Luminary' AI rating from Everest Group, supporting 80% of FDA approvals with up to 37% faster patient enrollment.
DASTYagentic AIclinical development